Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Woman reading the article on multiparametric MRI in prostate cancer treatments on her laptop

Use of Multiparametric MRI in Prostate Cancer Treatments: A Prospective Study

The prospective study conducted by LMU Klinikum München investigates the effectiveness of vascular-targeted photodynamic therapy (VTP) and high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer.

Using multiparametric MRI (mpMRI), ten patients were monitored over the course of one year to track anatomical changes and potential tumor recurrence.

The results show that mpMRI reliably captures changes in prostate and tumor volumes, with an initial increase in prostate volume, followed by a significant reduction after one year. A recurrence was detected in one patient.

mpMRI proves to be a valuable tool for monitoring tumor recurrence, but further validation in larger studies is required.

Read more about the study here.

Related Resources

Related Resources

A diagram and a CT scan visualizing tumor growth rate in patients with refractory or relapsed lymphoma

Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients

A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™  on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…